Scientists Identify Antibodies With Potential to Block COVID-19 Virus

Journal Science published the study of antibodies that could potentially block the virus

Coronavirus
Scientists have found a pair of antibodies which could pottentially block the COVID-19 virus. Pixabay

From a patient who recovered from COVID-19, scientists have isolated a pair of neutralising antibodies that could potentially block the virus responsible for the pandemic from entering into host cells.

The study, published in the journal Science, suggests that a “cocktail” containing both antibodies could provide direct therapeutic benefits for COVID-19 patients.

The new information detailed in the study could also aid the development of small molecule antivirals and vaccine candidates to fight the SARS-CoV-2 virus which causes COVID-19.

The twin antibodies identified by the researchers are named B38 and H4.

The study by Yan Wu from Chinese Academy of Sciences and colleagues found that the two antibodies bind to the glycoprotein spike of the SARS-CoV-2 virus and thereby block the entry of the virus into host cells.

doctors
The twin antibodies identified by the researchers are named B38 and H4. (Representational Image). Pixabay

Read More: Realme Global User Base Reaches 3.5 Crore, 2.1 crore in India Alone

Preliminary tests of the two antibodies in a mouse model resulted in a reduction of virus titers, suggesting that the antibodies may offer therapeutic benefits.

The researchers found that the antibodies can each bind simultaneously to different epitopes on the spike’s receptor binding domain (RBD), such that both antibodies together may confer a stronger neutralising effect than either antibody on its own — a prediction supported by in vitro experiments.

This feature also means that, should one of the viral epitopes mutate in a way that prevents the binding of one of the two antibodies, the other antibody may yet retain its neutralising activity. (IANS)

LEAVE A REPLY

Please enter your comment!
Please enter your name here